Epithelial cell adhesion molecule

BCC with squamous cell metaplasia with HE and BerEP4 staining

Epithelial Cell Adhesion Molecule (EpCAM), also known as CD326, is a cell adhesion molecule that is prominently expressed on the surface of epithelial cells. EpCAM plays a crucial role in cell signaling, proliferation, differentiation, and migration, which are vital processes for embryonic development, tissue formation, and wound healing. Its expression is also significant in the context of cancer, where it is associated with the proliferation and metastasis of carcinoma cells, making it a target for cancer diagnosis and therapy.

Function

EpCAM functions primarily as an adhesion molecule, facilitating cell-cell interactions within epithelial tissues. It participates in the formation and maintenance of the epithelial cell layer, acting as a mediator in the intercellular junctions that are essential for the structural and functional integrity of epithelial tissues. Beyond its role in adhesion, EpCAM is involved in intracellular signaling pathways that regulate cell proliferation and differentiation. The activation of EpCAM can lead to the modulation of genes that are critical for cell cycle progression and the maintenance of the epithelial phenotype.

Structure

The structure of EpCAM comprises a single transmembrane domain, a large extracellular domain responsible for mediating cell adhesion, and a short intracellular domain involved in signaling pathways. The extracellular domain contains an epidermal growth factor (EGF)-like domain and a thyroglobulin type-1A domain, which are key to its adhesion and signaling functions.

Clinical Significance

EpCAM is overexpressed in many types of human carcinomas, including breast, colon, and prostate cancer, making it a marker for the presence and progression of these diseases. Its overexpression is often correlated with increased proliferation and metastasis of tumor cells. Consequently, EpCAM has been explored as a target for cancer therapy, including the development of monoclonal antibodies that can specifically bind to EpCAM on tumor cells and mediate their destruction.

In addition to its role in cancer, alterations in EpCAM expression or function have been implicated in other diseases, such as congenital tufting enteropathy, a rare autosomal recessive disorder affecting the intestine's epithelial layer.

EpCAM in Cancer Diagnosis and Therapy

The detection of EpCAM expression on circulating tumor cells (CTCs) has been utilized in the diagnosis and monitoring of cancer. Techniques such as immunohistochemistry and flow cytometry can identify CTCs based on EpCAM expression, providing valuable information on disease progression and response to therapy.

Therapeutically, EpCAM has been targeted using various approaches, including monoclonal antibodies, antibody-drug conjugates, and CAR-T cell therapy. These strategies aim to exploit the high expression of EpCAM on tumor cells to deliver therapeutic agents or to direct immune-mediated destruction of these cells.

Conclusion

EpCAM is a critical molecule in the maintenance of epithelial tissue integrity and plays a significant role in the pathogenesis of various cancers. Its functions in cell adhesion, proliferation, and differentiation, along with its clinical significance in cancer diagnosis and therapy, make it an important subject of research in cell biology and oncology.